Regulatory FDA clears Denali drug in ‘clear step’ for rare disease biotechs pharminent March 26, 2026
Clinical Data Wave crashes on obesity drug update; Kodiak’s reboot pays dividends pharminent March 26, 2026
M&A / Deals Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug pharminent March 25, 2026
M&A / Deals Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases pharminent March 24, 2026
Clinical Data Karyopharm myeloma drug yields mixed data in myelofibrosis trial pharminent March 24, 2026
M&A / Deals Immutrin raises $87M to advance drug for progressive heart disease pharminent March 24, 2026
Regulatory FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares pharminent March 24, 2026
Other NOW AVAILABLE: The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers pharminent March 24, 2026
Business Pipeline How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup pharminent March 24, 2026
Regulatory Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results pharminent March 23, 2026
